Mainstream

Adicet Bio receives FDA Fast Track designation for its systemic sclerosis treatment

Adicet Bio receives FDA Fast Track designation for its systemic sclerosis treatment

Post ContentacetRead More

You might also be interested in reading Century Aluminum projects $75M-$85M Q1 2025 EBITDA amid rising aluminum prices.

February 27, 2025
In Mainstream